A 2024 state law reclassified misoprostol and mifepristone as controlled substances. That affects how hospitals can access the drugs in non-abortion emergencies, and other states appear to be taking note.
A 2024 state law reclassified misoprostol and mifepristone as controlled substances. That affects how hospitals can access the drugs in non-abortion emergencies, and other states appear to be taking note.
<iframe src="https://statesidedaily.com/embed/cluster/9577c4093c597592b649feb6d83c56196d80cbcc" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients"></iframe>
